NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...

Taking a private company public through an Initial Public Offering (IPO) is a complex journey involving multiple steps. In India, this transition goes beyond just raising funds. It’s a major milestone ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Production efficiency is a point where ...